JP2021523918A5 - - Google Patents
Info
- Publication number
- JP2021523918A5 JP2021523918A5 JP2020564243A JP2020564243A JP2021523918A5 JP 2021523918 A5 JP2021523918 A5 JP 2021523918A5 JP 2020564243 A JP2020564243 A JP 2020564243A JP 2020564243 A JP2020564243 A JP 2020564243A JP 2021523918 A5 JP2021523918 A5 JP 2021523918A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- pyrazolo
- pyridine
- methyl
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023212606A JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/087448 | 2018-05-18 | ||
| CN2018087448 | 2018-05-18 | ||
| PCT/IB2019/054066 WO2019220390A1 (en) | 2018-05-18 | 2019-05-16 | Crystalline forms of a tlr7/tlr8 inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212606A Division JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523918A JP2021523918A (ja) | 2021-09-09 |
| JP2021523918A5 true JP2021523918A5 (https=) | 2022-05-20 |
| JP7407740B2 JP7407740B2 (ja) | 2024-01-04 |
Family
ID=67145832
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564243A Active JP7407740B2 (ja) | 2018-05-18 | 2019-05-16 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
| JP2023212606A Pending JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212606A Pending JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12084460B2 (https=) |
| EP (1) | EP3793998A1 (https=) |
| JP (2) | JP7407740B2 (https=) |
| KR (1) | KR20210013554A (https=) |
| CN (1) | CN112119078A (https=) |
| AR (1) | AR117573A1 (https=) |
| AU (1) | AU2019268583B2 (https=) |
| BR (1) | BR112020022738A2 (https=) |
| CA (1) | CA3097312A1 (https=) |
| CL (1) | CL2020002967A1 (https=) |
| MX (2) | MX2020012259A (https=) |
| TW (2) | TW202417000A (https=) |
| WO (1) | WO2019220390A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7328977B2 (ja) | 2018-02-12 | 2023-08-17 | エフ． ホフマン－ラ ロシュ アーゲー | ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体 |
| KR20210018818A (ko) | 2018-06-05 | 2021-02-18 | 에프. 호프만-라 로슈 아게 | 자가면역 질환의 치료를 위한 테트라하이드로-1H-피라지노[2,1-a]이소인돌릴퀴놀린 화합물 |
| EP3807270B1 (en) | 2018-06-12 | 2023-09-13 | F. Hoffmann-La Roche AG | Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease |
| US11952363B2 (en) | 2018-07-23 | 2024-04-09 | Hoffmann-La Roche Inc. | Piperazine compounds for the treatment of autoimmune disease |
| WO2020048583A1 (en) | 2018-09-04 | 2020-03-12 | F. Hoffmann-La Roche Ag | Benzothiazole compounds for the treatment of autoimmune diseases |
| WO2020048595A1 (en) | 2018-09-06 | 2020-03-12 | F. Hoffmann-La Roche Ag | Novel cyclic amidine compounds for the treatment of autoimmune disease |
| JP7367004B2 (ja) | 2018-09-06 | 2023-10-23 | エフ． ホフマン－ラ ロシュ アーゲー | 自己免疫疾患の処置のための新規のピラゾロビリジン化合物 |
| US12421240B2 (en) | 2019-10-31 | 2025-09-23 | Hoffmann-La Roche Inc. | Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease |
| JP2023502087A (ja) | 2019-11-19 | 2023-01-20 | エフ．ホフマン－ラ ロシュ アーゲー | 自己免疫疾患の処置のためのヒドロ－１Ｈ－ピロロ［１，２－ａ］ピラジン化合物 |
| JP7649306B2 (ja) | 2019-11-20 | 2025-03-19 | エフ． ホフマン－ラ ロシュ アーゲー | 自己免疫疾患の処置のためのスピロ（イソベンゾフラナゼチジン）化合物 |
| WO2022013136A1 (en) | 2020-07-14 | 2022-01-20 | F. Hoffmann-La Roche Ag | Hydroisoquinoline or hydronaphthyridine compounds for the treatment of autoimmune disease |
| KR20230171469A (ko) | 2021-04-16 | 2023-12-20 | 길리애드 사이언시즈, 인코포레이티드 | 티에노피롤 화합물 |
| EP4398989A1 (en) | 2021-09-10 | 2024-07-17 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| AU2022351495A1 (en) | 2021-09-24 | 2024-02-01 | F. Hoffmann-La Roche Ag | Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune disease |
| TW202337443A (zh) * | 2022-01-11 | 2023-10-01 | 瑞士商諾華公司 | 使用ｔｌｒ７／８拮抗劑治療ｓｊｏｇｒｅｎ氏症候群或混合性結締組織病之方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2222545A1 (en) | 1995-06-07 | 1996-12-19 | Sugen, Inc. | Quinazolines and pharmaceutical compositions |
| MX2008002207A (es) | 2005-08-16 | 2008-03-27 | Memory Pharm Corp | Inhibidores de fosfodiesterasa 10. |
| ES2637113T3 (es) | 2011-01-10 | 2017-10-10 | Infinity Pharmaceuticals, Inc. | Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas |
| SG11201404743TA (en) | 2012-02-08 | 2014-09-26 | Janssen R & D Ireland | Piperidino-pyrimidine derivatives for the treatment of viral infections |
| KR101810798B1 (ko) | 2013-07-30 | 2017-12-19 | 질레드 코네티컷 인코포레이티드 | Ｓｙｋ 억제제의 다형체 |
| EA037366B1 (ru) | 2015-08-25 | 2021-03-18 | Бейджин, Лтд. | Способ получения ингибитора parp, кристаллические формы и их применения |
| US11998432B2 (en) * | 2016-06-30 | 2024-06-04 | Kimberly-Clark Worldwide, Inc. | Method of manufacturing a foam and fiber composite |
| CR20190119A (es) * | 2016-09-09 | 2019-06-03 | Novartis Ag | Compuestos y composiciones como inhibidores de los receptores endosomales tipo peaje |
-
2019
- 2019-05-16 JP JP2020564243A patent/JP7407740B2/ja active Active
- 2019-05-16 TW TW112150642A patent/TW202417000A/zh unknown
- 2019-05-16 CA CA3097312A patent/CA3097312A1/en active Pending
- 2019-05-16 CN CN201980032642.0A patent/CN112119078A/zh active Pending
- 2019-05-16 BR BR112020022738-2A patent/BR112020022738A2/pt unknown
- 2019-05-16 EP EP19735624.9A patent/EP3793998A1/en not_active Withdrawn
- 2019-05-16 AR ARP190101308A patent/AR117573A1/es not_active Application Discontinuation
- 2019-05-16 KR KR1020207032942A patent/KR20210013554A/ko not_active Ceased
- 2019-05-16 US US17/056,351 patent/US12084460B2/en active Active
- 2019-05-16 AU AU2019268583A patent/AU2019268583B2/en not_active Ceased
- 2019-05-16 TW TW108116864A patent/TWI826446B/zh active
- 2019-05-16 MX MX2020012259A patent/MX2020012259A/es unknown
- 2019-05-16 WO PCT/IB2019/054066 patent/WO2019220390A1/en not_active Ceased
-
2020
- 2020-11-13 MX MX2023013584A patent/MX2023013584A/es unknown
- 2020-11-16 CL CL2020002967A patent/CL2020002967A1/es unknown
-
2023
- 2023-12-18 JP JP2023212606A patent/JP2024037930A/ja active Pending
-
2024
- 2024-08-06 US US18/795,371 patent/US20240391938A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523918A5 (https=) | ||
| AU2019283921B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| CN111315737B (zh) | 经砜吡啶烷基酰胺取代的杂芳基化合物 | |
| TWI287545B (en) | New pyridazin-3(2h)-one derivatives | |
| JP4142621B2 (ja) | 純結晶形態の５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニルおよび合成方法 | |
| CN110256421A (zh) | Kras-g12c抑制剂 | |
| TW200526593A (en) | New pyridazin-3(2H)-one derivatives | |
| EP3209652B1 (en) | Tricyclic atropisomer compounds | |
| JP2006503845A (ja) | Ｃｂ２受容体モジュレーターとしてのピリジン誘導体 | |
| JP2009515836A5 (https=) | ||
| PT3013814T (pt) | Compostos de tetrahidrocarbazol e carbazol carboxamida substituídos úteis como inibidores de quinases | |
| JP2002515433A (ja) | 抗ウイルス化合物 | |
| CN116113416A (zh) | 四环类衍生物、其制备方法和其医药上的用途 | |
| JP2020507624A5 (https=) | ||
| JP2005529084A (ja) | 結晶性パレコキシブナトリウム | |
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| WO2024251080A1 (zh) | 3,4-二氢酞嗪-1(2h)-酮类衍生物及其制备方法和用途 | |
| CN104994851A (zh) | 作为crac通道抑制剂的基于吡唑基的甲酰胺i | |
| JP2016516691A (ja) | カリウムイオンチャネル阻害剤としてのイソキノリン | |
| JP2005529084A5 (https=) | ||
| JP2008515980A (ja) | 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 | |
| JP6473820B2 (ja) | 塩酸ヨンケナフィルの多形体及びその調製方法、組成物並びに用途 | |
| JP2004530706A (ja) | 純粋な結晶形態にある５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニル及び合成方法 | |
| CN104884058A (zh) | 作为crac通道抑制剂的基于吡唑基的甲酰胺ii | |
| EP3495350B1 (en) | Compound inhibiting formation of c-myc/max/dna complex |